$115 Million Stock Offering by California State-backed Biotech Firm, Forty Seven, Inc.
A California company backed by the state's stem cell agency has announced that it is planning a $115 million initial public offering.
The firm -- Forty Seven, Inc., of Menlo Park -- filed a notice of its plans with the Security and Exchange Commission last Friday. The company has been awarded $15.2 million from the California Institute for Regenerative M…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.